BSE - Delayed Quote • INR
Transgene Biotek Limited (TRABI.BO)
At close: April 26 at 3:29 PM GMT+5:30
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,898.85
550.85
866.95
1,695.50
Cost of Revenue
643.16
663.16
-462.13
608.28
Gross Profit
1,255.68
-112.32
1,329.08
1,087.22
Operating Expense
14,033.20
53,738.20
103,429.54
103,638.06
Operating Income
-12,777.51
-53,850.51
-102,100.46
-102,550.84
Net Non Operating Interest Income Expense
-5,844.47
-6,235.47
-2,291.03
-2,711.10
Pretax Income
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Net Income Common Stockholders
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Diluted NI Available to Com Stockholders
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Basic EPS
-0.24
-0.79
-1.37
-1.38
Diluted EPS
-0.24
-0.79
-1.37
-1.38
Basic Average Shares
77,646.25
75,770.00
75,770.00
75,770.00
Diluted Average Shares
77,646.25
75,770.00
75,770.00
75,770.00
Total Expenses
14,676.36
54,401.36
102,967.41
104,246.34
Net Income from Continuing & Discontinued Operation
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Normalized Income
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Interest Expense
5,844.45
6,235.45
2,290.97
2,709.92
Net Interest Income
-5,844.47
-6,235.47
-2,291.03
-2,711.10
EBIT
-12,776.54
-53,850.54
-101,729.08
-101,636.92
EBITDA
290.31
-4,349.69
-2,485.52
-2,556.46
Reconciled Cost of Revenue
643.16
663.16
-462.13
608.28
Reconciled Depreciation
13,066.84
49,500.84
99,243.56
99,080.46
Net Income from Continuing Operation Net Minority Interest
-18,620.99
-60,085.99
-104,020.05
-104,346.84
Normalized EBITDA
290.31
-4,349.69
-2,485.52
-2,556.46
3/31/2021 - 12/31/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade